Global DNA methylation not increased in chronic hemodialysis patients

A case-Control study

Chiao Ying Hsu, Chiao Yin Sun, Chin Chan Lee, I. Wen Wu, Heng Jung Hsu, Mai Szu Wu

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Patients with chronic kidney disease have an increased risk of cardiovascular disease and mortality. Since DNA methylation is an important mechanism modulating the gene expression associated with aging, inflammation, and atherosclerosis, the objective of this study was to determine the possible effect of the uremic milieu on global DNA methylation and DNA methyltransferase (DNMT) expression in uremic status by comparing chronic hemodialysis (HD) patients with the normal population. Twenty normal subjects and twenty chronic dialysis patients with similar ages, sex, and body mass indexes (BMIs) were included. We evaluated the clinical characteristics; the levels of homocysteine, total indoxyl sulfate (IS), and total p-cresol sulfate (PCS); and the DNMT messenger RNA expression and global DNA methylation in the peripheral blood leukocytes. The chronic HD patients had significantly higher blood urea nitrogen (BUN), creatinine (Cr), uric acid, Ca, P, intact parathyroid harmone (iPTH), cholesterol, high-sensitivity C-reactive protein (hs-CRP), total indoxyl sulphate (IS) and p-cresol sulphate (PCS), and homocysteine than the normal subjects. The expression of DNMT 1 and 3a did not differ significantly between these two study groups. The chronic HD patients had significantly decreased DNMT 3b expression in the leukocytes. There were no significant correlations between the global DNA methylation and the levels of IS, PCS, and homocysteine. We concluded that chronic HD patients may have lower DNMT 3b expression than normal subjects. However, the status of global DNA methylation may not change significantly in uremic patients when compared with the normal population.

Original languageEnglish
Pages (from-to)1195-1199
Number of pages5
JournalRenal Failure
Volume34
Issue number10
DOIs
Publication statusPublished - Nov 2012

Fingerprint

DNA Methylation
Renal Dialysis
Case-Control Studies
Indican
Homocysteine
Methyltransferases
Leukocytes
Blood Urea Nitrogen
DNA
Uric Acid
Chronic Renal Insufficiency
C-Reactive Protein
Population
Dialysis
Creatinine
Atherosclerosis
Body Mass Index
Cardiovascular Diseases
Cholesterol
Inflammation

Keywords

  • DNA methylation
  • Homocysteine
  • Indoxyl sulfate
  • p-cresol sulfate
  • Uremia

ASJC Scopus subject areas

  • Nephrology
  • Critical Care and Intensive Care Medicine

Cite this

Global DNA methylation not increased in chronic hemodialysis patients : A case-Control study. / Hsu, Chiao Ying; Sun, Chiao Yin; Lee, Chin Chan; Wu, I. Wen; Hsu, Heng Jung; Wu, Mai Szu.

In: Renal Failure, Vol. 34, No. 10, 11.2012, p. 1195-1199.

Research output: Contribution to journalArticle

Hsu, Chiao Ying ; Sun, Chiao Yin ; Lee, Chin Chan ; Wu, I. Wen ; Hsu, Heng Jung ; Wu, Mai Szu. / Global DNA methylation not increased in chronic hemodialysis patients : A case-Control study. In: Renal Failure. 2012 ; Vol. 34, No. 10. pp. 1195-1199.
@article{c8227a7f229243df9c4c2a34000acd40,
title = "Global DNA methylation not increased in chronic hemodialysis patients: A case-Control study",
abstract = "Patients with chronic kidney disease have an increased risk of cardiovascular disease and mortality. Since DNA methylation is an important mechanism modulating the gene expression associated with aging, inflammation, and atherosclerosis, the objective of this study was to determine the possible effect of the uremic milieu on global DNA methylation and DNA methyltransferase (DNMT) expression in uremic status by comparing chronic hemodialysis (HD) patients with the normal population. Twenty normal subjects and twenty chronic dialysis patients with similar ages, sex, and body mass indexes (BMIs) were included. We evaluated the clinical characteristics; the levels of homocysteine, total indoxyl sulfate (IS), and total p-cresol sulfate (PCS); and the DNMT messenger RNA expression and global DNA methylation in the peripheral blood leukocytes. The chronic HD patients had significantly higher blood urea nitrogen (BUN), creatinine (Cr), uric acid, Ca, P, intact parathyroid harmone (iPTH), cholesterol, high-sensitivity C-reactive protein (hs-CRP), total indoxyl sulphate (IS) and p-cresol sulphate (PCS), and homocysteine than the normal subjects. The expression of DNMT 1 and 3a did not differ significantly between these two study groups. The chronic HD patients had significantly decreased DNMT 3b expression in the leukocytes. There were no significant correlations between the global DNA methylation and the levels of IS, PCS, and homocysteine. We concluded that chronic HD patients may have lower DNMT 3b expression than normal subjects. However, the status of global DNA methylation may not change significantly in uremic patients when compared with the normal population.",
keywords = "DNA methylation, Homocysteine, Indoxyl sulfate, p-cresol sulfate, Uremia",
author = "Hsu, {Chiao Ying} and Sun, {Chiao Yin} and Lee, {Chin Chan} and Wu, {I. Wen} and Hsu, {Heng Jung} and Wu, {Mai Szu}",
year = "2012",
month = "11",
doi = "10.3109/0886022X.2012.723280",
language = "English",
volume = "34",
pages = "1195--1199",
journal = "Renal Failure",
issn = "0886-022X",
publisher = "Informa Healthcare",
number = "10",

}

TY - JOUR

T1 - Global DNA methylation not increased in chronic hemodialysis patients

T2 - A case-Control study

AU - Hsu, Chiao Ying

AU - Sun, Chiao Yin

AU - Lee, Chin Chan

AU - Wu, I. Wen

AU - Hsu, Heng Jung

AU - Wu, Mai Szu

PY - 2012/11

Y1 - 2012/11

N2 - Patients with chronic kidney disease have an increased risk of cardiovascular disease and mortality. Since DNA methylation is an important mechanism modulating the gene expression associated with aging, inflammation, and atherosclerosis, the objective of this study was to determine the possible effect of the uremic milieu on global DNA methylation and DNA methyltransferase (DNMT) expression in uremic status by comparing chronic hemodialysis (HD) patients with the normal population. Twenty normal subjects and twenty chronic dialysis patients with similar ages, sex, and body mass indexes (BMIs) were included. We evaluated the clinical characteristics; the levels of homocysteine, total indoxyl sulfate (IS), and total p-cresol sulfate (PCS); and the DNMT messenger RNA expression and global DNA methylation in the peripheral blood leukocytes. The chronic HD patients had significantly higher blood urea nitrogen (BUN), creatinine (Cr), uric acid, Ca, P, intact parathyroid harmone (iPTH), cholesterol, high-sensitivity C-reactive protein (hs-CRP), total indoxyl sulphate (IS) and p-cresol sulphate (PCS), and homocysteine than the normal subjects. The expression of DNMT 1 and 3a did not differ significantly between these two study groups. The chronic HD patients had significantly decreased DNMT 3b expression in the leukocytes. There were no significant correlations between the global DNA methylation and the levels of IS, PCS, and homocysteine. We concluded that chronic HD patients may have lower DNMT 3b expression than normal subjects. However, the status of global DNA methylation may not change significantly in uremic patients when compared with the normal population.

AB - Patients with chronic kidney disease have an increased risk of cardiovascular disease and mortality. Since DNA methylation is an important mechanism modulating the gene expression associated with aging, inflammation, and atherosclerosis, the objective of this study was to determine the possible effect of the uremic milieu on global DNA methylation and DNA methyltransferase (DNMT) expression in uremic status by comparing chronic hemodialysis (HD) patients with the normal population. Twenty normal subjects and twenty chronic dialysis patients with similar ages, sex, and body mass indexes (BMIs) were included. We evaluated the clinical characteristics; the levels of homocysteine, total indoxyl sulfate (IS), and total p-cresol sulfate (PCS); and the DNMT messenger RNA expression and global DNA methylation in the peripheral blood leukocytes. The chronic HD patients had significantly higher blood urea nitrogen (BUN), creatinine (Cr), uric acid, Ca, P, intact parathyroid harmone (iPTH), cholesterol, high-sensitivity C-reactive protein (hs-CRP), total indoxyl sulphate (IS) and p-cresol sulphate (PCS), and homocysteine than the normal subjects. The expression of DNMT 1 and 3a did not differ significantly between these two study groups. The chronic HD patients had significantly decreased DNMT 3b expression in the leukocytes. There were no significant correlations between the global DNA methylation and the levels of IS, PCS, and homocysteine. We concluded that chronic HD patients may have lower DNMT 3b expression than normal subjects. However, the status of global DNA methylation may not change significantly in uremic patients when compared with the normal population.

KW - DNA methylation

KW - Homocysteine

KW - Indoxyl sulfate

KW - p-cresol sulfate

KW - Uremia

UR - http://www.scopus.com/inward/record.url?scp=84867737739&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867737739&partnerID=8YFLogxK

U2 - 10.3109/0886022X.2012.723280

DO - 10.3109/0886022X.2012.723280

M3 - Article

VL - 34

SP - 1195

EP - 1199

JO - Renal Failure

JF - Renal Failure

SN - 0886-022X

IS - 10

ER -